
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6624184
[patent_doc_number] => 20100034740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'RADIOFLUORINATION METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/518728
[patent_app_country] => US
[patent_app_date] => 2007-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4400
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20100034740.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518728
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518728 | Radiofluorination methods | Dec 26, 2007 | Issued |
Array
(
[id] => 8339685
[patent_doc_number] => 08241606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Synthesis of a radiofluorinated peptide using photolabile protecting groups'
[patent_app_type] => utility
[patent_app_number] => 12/518279
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4571
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12518279
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518279 | Synthesis of a radiofluorinated peptide using photolabile protecting groups | Dec 17, 2007 | Issued |
Array
(
[id] => 8955389
[patent_doc_number] => 08501159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application'
[patent_app_type] => utility
[patent_app_number] => 12/519682
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12622
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519682
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/519682 | Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application | Dec 17, 2007 | Issued |
Array
(
[id] => 4745252
[patent_doc_number] => 20080089854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Skin care compositions'
[patent_app_type] => utility
[patent_app_number] => 12/001942
[patent_app_country] => US
[patent_app_date] => 2007-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001942
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001942 | Skin care compositions | Dec 12, 2007 | Abandoned |
Array
(
[id] => 4746155
[patent_doc_number] => 20080090757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Kahalalide Compositions for the Treatment of Psoriasis'
[patent_app_type] => utility
[patent_app_number] => 11/950144
[patent_app_country] => US
[patent_app_date] => 2007-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090757.pdf
[firstpage_image] =>[orig_patent_app_number] => 11950144
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950144 | Kahalalide Compositions for the Treatment of Psoriasis | Dec 3, 2007 | Abandoned |
Array
(
[id] => 6109999
[patent_doc_number] => 20110189101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'FLUORESCENT LABELING AGENT AND FLUORESCENT LABELING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/312876
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5786
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189101.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312876 | FLUORESCENT LABELING AGENT AND FLUORESCENT LABELING METHOD | Nov 28, 2007 | Abandoned |
Array
(
[id] => 4753285
[patent_doc_number] => 20080161360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes'
[patent_app_type] => utility
[patent_app_number] => 11/985032
[patent_app_country] => US
[patent_app_date] => 2007-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15202
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985032 | Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes | Nov 11, 2007 | Issued |
Array
(
[id] => 6314956
[patent_doc_number] => 20100112077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/513843
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 52169
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20100112077.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513843
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513843 | NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER | Nov 5, 2007 | Abandoned |
Array
(
[id] => 273933
[patent_doc_number] => 07560097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system'
[patent_app_type] => utility
[patent_app_number] => 11/924961
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17418
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924961 | Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system | Oct 25, 2007 | Issued |
Array
(
[id] => 4938368
[patent_doc_number] => 20080075687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'OPHTHALMIC COMPOSITIONS CONTAINING A SYNERGISTIC COMBINATION OF THREE POLYMERS'
[patent_app_type] => utility
[patent_app_number] => 11/874490
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4434
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20080075687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874490
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874490 | Ophthalmic compositions containing a synergistic combination of three polymers | Oct 17, 2007 | Issued |
Array
(
[id] => 8080965
[patent_doc_number] => 08147802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Chelator-functionalized nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 11/864453
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5962
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/147/08147802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11864453
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/864453 | Chelator-functionalized nanoparticles | Sep 27, 2007 | Issued |
Array
(
[id] => 10114596
[patent_doc_number] => 09149460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Coated particles and pharmaceutical dosage forms'
[patent_app_type] => utility
[patent_app_number] => 11/862470
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14421
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11862470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862470 | Coated particles and pharmaceutical dosage forms | Sep 26, 2007 | Issued |
Array
(
[id] => 5984367
[patent_doc_number] => 20110097268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'RADIOHALOIMATINIBS AND METHODS OF THEIR SYNTHESIS AND USE IN PET IMAGING OF CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/310333
[patent_app_country] => US
[patent_app_date] => 2007-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6409
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310333
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310333 | RADIOHALOIMATINIBS AND METHODS OF THEIR SYNTHESIS AND USE IN PET IMAGING OF CANCERS | Aug 21, 2007 | Abandoned |
Array
(
[id] => 6071631
[patent_doc_number] => 20110046482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'METHODS FOR REDUCING TOXICITIES ASSOCIATED WITH MEDICAL PROCEDURES EMPLOYING RADIOGRAPHIC CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/377840
[patent_app_country] => US
[patent_app_date] => 2007-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5196
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377840 | METHODS FOR REDUCING TOXICITIES ASSOCIATED WITH MEDICAL PROCEDURES EMPLOYING RADIOGRAPHIC CONTRAST AGENTS | Aug 15, 2007 | Abandoned |
Array
(
[id] => 5415786
[patent_doc_number] => 20090041673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Thermally Crosslinked Contrast Agents'
[patent_app_type] => utility
[patent_app_number] => 11/833873
[patent_app_country] => US
[patent_app_date] => 2007-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11885
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11833873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/833873 | Thermally Crosslinked Contrast Agents | Aug 2, 2007 | Abandoned |
Array
(
[id] => 4802561
[patent_doc_number] => 20080014148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Perturbed membrane-binding compounds and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/882490
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13926
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014148.pdf
[firstpage_image] =>[orig_patent_app_number] => 11882490
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/882490 | Perturbed membrane-binding compounds and methods of using the same | Aug 1, 2007 | Issued |
Array
(
[id] => 4866455
[patent_doc_number] => 20080145514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Compositions and methods for coating medical implants'
[patent_app_type] => utility
[patent_app_number] => 11/888615
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 50775
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888615
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888615 | Compositions and methods for coating medical implants | Jul 30, 2007 | Abandoned |
Array
(
[id] => 5029000
[patent_doc_number] => 20070270447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Compositions and methods for coating medical implants'
[patent_app_type] => utility
[patent_app_number] => 11/888511
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 50795
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888511
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888511 | Compositions and methods for coating medical implants | Jul 30, 2007 | Abandoned |
Array
(
[id] => 4903587
[patent_doc_number] => 20080113000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Compositions and methods for coating medical implants'
[patent_app_type] => utility
[patent_app_number] => 11/888624
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 50784
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113000.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888624 | Compositions and methods for coating medical implants | Jul 30, 2007 | Abandoned |
Array
(
[id] => 4657191
[patent_doc_number] => 20080026052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats'
[patent_app_type] => utility
[patent_app_number] => 11/831741
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29106
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11831741
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/831741 | Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats | Jul 30, 2007 | Abandoned |